Agios Pharmaceuticals (AGIO) News Today $27.82 +0.30 (+1.09%) Closing price 04:00 PM EasternExtended Trading$27.82 0.00 (-0.02%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Kennedy Capital Management LLC Grows Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Kennedy Capital Management LLC grew its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 281.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 111,098 shares of the biopharmaceutical comApril 15 at 6:02 AM | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Martingale Asset Management L PMartingale Asset Management L P trimmed its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 56.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,520 shares of the biopharmaceutical companApril 15 at 5:45 AM | marketbeat.comFranklin Resources Inc. Purchases 30,144 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Franklin Resources Inc. increased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 83.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 66,461 shares of the biopharmaceutical company's stock after buying an additional 30,144 sharesApril 15 at 3:31 AM | marketbeat.comZacks Research Issues Pessimistic Forecast for AGIO EarningsApril 15 at 1:33 AM | americanbankingnews.comEquities Analysts Offer Predictions for AGIO FY2025 EarningsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities research analysts at Zacks Research cut their FY2025 earnings per share estimates for Agios Pharmaceuticals in a report released on Wednesday, April 9th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceuticalApril 15 at 1:32 AM | marketbeat.comNorges Bank Purchases Shares of 145,092 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Norges Bank purchased a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 145,092 shares of the biopharmaceutical company's stock, valued at approximately $4,768,April 12 at 4:02 AM | marketbeat.comSei Investments Co. Sells 9,568 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Sei Investments Co. decreased its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 41.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,601 shares of the biopharmaceutical compaApril 12 at 3:18 AM | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Stake Lifted by CenterBook Partners LPCenterBook Partners LP raised its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 98.3% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 305,599 shares of the biopharmaceutical company's stock after buying an additional 151,511 sharApril 11, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Director Jacqualyn A. Fouse Sells 7,497 SharesApril 11, 2025 | insidertrades.comCapula Management Ltd Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Capula Management Ltd acquired a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 20,849 shares of the biopharmaceutical compApril 10, 2025 | marketbeat.comTrexquant Investment LP Grows Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Trexquant Investment LP grew its stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 180.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,971 shares of the biophaApril 9, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)JPMorgan Chase & Co. reduced its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 40.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,015,360 shares of the biopharmaceutical company's stock afApril 9, 2025 | marketbeat.comVanguard Group Inc. Boosts Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Vanguard Group Inc. raised its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,631,321 shares of the biopharmaceutical companApril 8, 2025 | marketbeat.comMBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of DirectorsApril 7, 2025 | finance.yahoo.comKLP Kapitalforvaltning AS Makes New $329,000 Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)KLP Kapitalforvaltning AS bought a new stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 10,000 shares of the biopharmaceutical companyApril 7, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Sets New 1-Year Low - What's Next?Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year Low - Should You Sell?April 6, 2025 | marketbeat.comHeadlands Technologies LLC Buys 12,989 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Headlands Technologies LLC increased its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 94.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,736 shares of the biopharmaceuticalApril 4, 2025 | marketbeat.comPictet Asset Management Holding SA Sells 46,394 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Pictet Asset Management Holding SA lowered its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 11.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 354,455 sharesApril 4, 2025 | marketbeat.comAgios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.4% - What's Next?Agios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.4% - Here's What HappenedApril 3, 2025 | marketbeat.comShort Interest in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Declines By 13.7%Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 3,400,000 shares, a decline of 13.7% from the February 28th total of 3,940,000 shares. Based on an average daily trading volume, of 781,700 shares, the short-interest ratio is presently 4.3 days. Currently, 6.2% of the company's stock are sold short.April 3, 2025 | marketbeat.comPrudential Financial Inc. Boosts Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Prudential Financial Inc. lifted its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 111.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 104,922 shares of the biopharmaceutical company's stock after acquiring an additional 55,April 3, 2025 | marketbeat.comMOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management TeamApril 1, 2025 | finance.yahoo.comLoomis Sayles & Co. L P Trims Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Loomis Sayles & Co. L P lowered its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 31.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 417,208 shares of the biopharmaceutical company's stock after selling 195March 30, 2025 | marketbeat.comArtisan Partners Limited Partnership Purchases 107,292 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Artisan Partners Limited Partnership boosted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 27.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 499,134 sharesMarch 30, 2025 | marketbeat.comIs Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) the Best Small Cap Stock to Buy Before They Explode?March 27, 2025 | msn.comAgios Pharmaceuticals (NASDAQ:AGIO) Shares Down 4.9% - Here's What HappenedAgios Pharmaceuticals (NASDAQ:AGIO) Trading Down 4.9% - Here's What HappenedMarch 26, 2025 | marketbeat.comFox Run Management L.L.C. Invests $783,000 in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Fox Run Management L.L.C. acquired a new position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 23,839 shares of theMarch 25, 2025 | marketbeat.comIntech Investment Management LLC Raises Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Intech Investment Management LLC boosted its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 40.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 28,248 shares of the biopharmaceutical company's stock after purchMarch 24, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommenMarch 22, 2025 | marketbeat.comAuron Therapeutics Expands Leadership with Appointment of Glenn Goddard as Chief Financial OfficerMarch 20, 2025 | markets.businessinsider.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Short Interest Down 14.9% in FebruaryAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) was the target of a large decrease in short interest during the month of February. As of February 28th, there was short interest totalling 3,940,000 shares, a decrease of 14.9% from the February 13th total of 4,630,000 shares. Based on an average daily trading volume, of 895,400 shares, the short-interest ratio is currently 4.4 days. Approximately 7.1% of the company's shares are sold short.March 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 464.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 125,678 shares of the bMarch 17, 2025 | marketbeat.comBank of New York Mellon Corp Purchases 87,089 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Bank of New York Mellon Corp raised its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 48.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 265,514 shares of the biopharmaceuticaMarch 15, 2025 | marketbeat.comErste Asset Management GmbH Has $66.43 Million Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Erste Asset Management GmbH lowered its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 8.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,009,900 shares ofMarch 13, 2025 | marketbeat.comQ1 EPS Estimate for Agios Pharmaceuticals Lowered by AnalystAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a report issued on Thursday, March 6th. Zacks Research analyst A. Chakraborty now expects that the biopharmaMarch 10, 2025 | marketbeat.comCandriam S.C.A. Sells 91,955 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Candriam S.C.A. cut its position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 35.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 169,550 shares of the biopharmaceutical company'March 9, 2025 | marketbeat.comBrokers Set Expectations for AGIO FY2027 EarningsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Zacks Research issued their FY2027 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst A. Chakraborty anticipates that tMarch 8, 2025 | marketbeat.comCelldex Therapeutics and Agios Pharmaceuticals to Present at March 2025 Investor ConferencesMarch 7, 2025 | theglobeandmail.comAgios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy OfficerMarch 5, 2025 | globenewswire.comAgios to Present at Upcoming Investor ConferencesMarch 4, 2025 | globenewswire.comAgios Pharmaceuticals (NASDAQ:AGIO) Shares Down 5.9% - Should You Sell?Agios Pharmaceuticals (NASDAQ:AGIO) Trading Down 5.9% - Here's WhyMarch 3, 2025 | marketbeat.comFisher Asset Management LLC Raises Stock Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)Fisher Asset Management LLC boosted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 12.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 960,661 shareMarch 3, 2025 | marketbeat.com10 Best Small-Cap Stocks to Buy NowMarch 2, 2025 | insidermonkey.comIs Agios Pharmaceuticals, Inc. (AGIO) the Best Small-Cap Stock to Buy Now?March 1, 2025 | insidermonkey.comResearch Analysts Issue Forecasts for AGIO Q1 EarningsAgios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 EPS estimates for Agios Pharmaceuticals in a research report issued to clients and investors on Monday, February 24th. HC Wainwright analyst E. Bodnar expects that the biopharmaceuticalFebruary 26, 2025 | marketbeat.com45,817 Shares in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Bought by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd bought a new position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 45,817 shares of the biopharmacFebruary 26, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for AGIO Q4 Earnings?Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - Stock analysts at HC Wainwright issued their Q4 2025 earnings per share (EPS) estimates for Agios Pharmaceuticals in a report issued on Monday, February 24th. HC Wainwright analyst E. Bodnar forecasts that the biopharmaceutical company wilFebruary 25, 2025 | marketbeat.comAgios Pharmaceuticals initiated with a Buy at H.C. WainwrightFebruary 24, 2025 | markets.businessinsider.comAgios Pharmaceuticals (NASDAQ:AGIO) Coverage Initiated at HC WainwrightHC Wainwright began coverage on shares of Agios Pharmaceuticals in a report on Monday. They issued a "buy" rating and a $58.00 price objective for the company.February 24, 2025 | marketbeat.comAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight research firms that are presently covering the company, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and four have giveFebruary 24, 2025 | marketbeat.com Remove Ads Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address AGIO Media Mentions By Week AGIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGIO News Sentiment▼1.040.80▲Average Medical News Sentiment AGIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGIO Articles This Week▼165▲AGIO Articles Average Week Remove Ads Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Legend Biotech News Telix Pharmaceuticals Limited American Depositary Shares News Sarepta Therapeutics News Blueprint Medicines News Axsome Therapeutics News Nuvalent News ADMA Biologics News Krystal Biotech News Grifols News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGIO) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AGIO Stock Free AGIO Stock Alerts